Identification and distribution of 5‐HT3 recognition sites in the rat gastrointestinal tract

• Published in: British journal of pharmacology Vol. 106; no. 3; pp. 693 - 696
• Main Authors: Champaneria, S., Costall, B., Naylor, R.J., Robertson, D.W.
• Format: Journal Article
• Language: English
• Published: Oxford, UK Blackwell Publishing Ltd 01.07.1992; Nature Publishing
• Subjects: 5‐HT3 recognition sites; [3H]‐GR65630; [3H]‐LY278584; Affinity Labels; Animals; Biological and medical sciences; Digestive System - chemistry; Female; Fundamental and applied biological sciences. Psychology; Imidazoles - metabolism; In Vitro Techniques; Indazoles - metabolism; Indoles - metabolism; Intestine, Small - chemistry; Radioligand Assay; rat intestine; Rats; Receptors, Serotonin - metabolism; Serotonin Antagonists; Stomach; Tissue Distribution; Tritium; Tropanes - metabolism; Vertebrates: digestive system; Stomach; Vertebrata; Mammalia; Rat; Digestive system; Animal; Rodentia; Distribution; Gut; S3 receptor; Identification; Gastrointestinal
• ISSN: 0007-1188; 1476-5381
• DOI: 10.1111/j.1476-5381.1992.tb14396.x

1 Tritiated derivatives of the potent and selective 5‐HT3 receptor antagonists GR65630 and LY278584 were used to identify 5‐HT3 recognition sites in the rat gastrointestinal tract. 2 Binding studies were carried out in homogenates of the rat oesophagus, the cardia, fundus, body and antrum of the stomach, regions of the small intestine, caecum and large intestine. The specific binding of a single concentration of GR65630 (0.5 nm) defined by granisetron (10 μm) in these areas indicated that the density of 5‐HT3 recognition sites varied from 2.4 ± 1.0 to 10.1 ± 1.0 fmol mg−1 protein. 3 Saturable binding of [3H]‐GR65630 could only be demonstrated in the terminal regions of the small intestine (Bmax in the range of 13.83 ± 4.54–21.19 ± 0.89 fmol mg−1 protein; mean ± s.e.mean) and of high affinity (Kd in the range of 0.42 ± 0.18–0.79 ± 0.24 nm). Use of [3H]‐LY278584 revealed a similar binding density (Bmax 19.54 ± 0.26 fmol mg−1 protein) and affinity (Kd 1.04 ± 0.07 nm) in the terminal small intestine. 4 Binding of [3H]‐GR65630 and [3H]‐LY278584 to the terminal region of the small intestine was inhibited by 5‐HT3 receptor ligands ondansetron and S‐zacopride (and 5‐hydroxytryptamine), but not by 5‐HT1, 5‐HT2, catecholamine, γ‐aminobutyric acid and opioid receptor ligands. 5 These data demonstrate that there are regional variations in the density of 5‐HT3 recognition sites within the rat gastrointestinal tract. Such data are relevant to the potential use of 5‐HT3 receptor ligands to modify secretory and contraction responses in the gastrointestinal system.